Analysis of an independent data set containing information from 295 patients [21] supports the observation that high expression ratios of DBN1 predict poor survival (adjusted P value of 0.03 and HR of 3.81) and indicates the same tendency as previously noted for low expression ratios of ABCA3, SP110 and SPTAN1 (non-adjusted HR of 0.31, 0.34 and 0.64, respectively), although this now appears non-significant when adjusted for tumor grade and ER status (adjusted HR of 0.61, 0.25 and 1.19). This evidence concerns the gene ABCA3 and neoplasm.